Market Research Logo

Sri Lanka Pharmaceuticals & Healthcare Q4 2019

Sri Lanka Pharmaceuticals & Healthcare Q4 2019

Key View:

Despite the recent hike in drug prices, Sri Lanka will remain a challenging market for pharmaceutical suppliers.Healthcare sector investment and development will act as a key driver of market growth over the next few years, ensuring improvedaccess to medical treatment. From a demand-side perspective, the growing burden of chronic diseases will ensure that demand formedical treatment remains high. However, the subdued regulatory and operating environment and the small absolute market sizewill continue to weigh on the market's growth potential.


Key View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Asia Pacific Innovative Pharmaceuticals Risk/Reward Index
Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
GlaxoSmithKline
Hemas Holdings
State Pharmaceuticals Corporation
Sri Lanka Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook